Skip to main content
PMC home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1996 Apr;72(2):98–102. doi: 10.1136/sti.72.2.98

Comparison of the efficacy and safety of oral fluconazole and topical clotrimazole in patients with candida balanitis.

A Stary 1, J Soeltz-Szoets 1, C Ziegler 1, G R Kinghorn 1, R B Roy 1
PMCID: PMC1195616  PMID: 8698375

Abstract

One hundred fifty seven men with candidal balanitis were entered in a randomised, open-label parallel-group multicentre study comparing efficacy and safety of a single oral 150-mg fluconazole-dose with clotrimazole applied topically twice daily for 7 days. Of 64 fluconazole and 68 clotrimazole treated patients who were evaluable at short term follow up, 92% and 91% respectively were clinically cured or improved. Candida albicans was eradicated in 78% and 83% of patients respectively. Median time to relief of erythema was 6 days for fluconazole and 7 days for clotrimazole. Twelve of 15 patients who had received previous topical therapy for balanitis said they preferred oral therapy. At the one month follow up visit, 24/36 and 29/33 patients in the two groups were clinically cured or improved. Nine in the fluconazole group experienced a relapse; 6 of these 9 patients reported previous episodes of this infection during the past year. Two patients in the clotrimazole group had a relapse; neither had a history of previous episodes. Mycological eradication was noted in 26/36 and 25/33 patients in the two groups. Both treatment regimens were well tolerated. Thus a single 150 mg dose of fluconazole was comparable in efficacy and safety to clotrimazole cream applied topically for 7 days when administered to patients with balanitis.

Full text

PDF
98

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdullah A. N., Drake S. M., Wade A. A., Walzman M. Balanitis (balanoposthitis) in patients attending a department of genitourinary medicine. Int J STD AIDS. 1992 Mar-Apr;3(2):128–129. doi: 10.1177/095646249200300211. [DOI] [PubMed] [Google Scholar]
  2. Brammer K. W., Farrow P. R., Faulkner J. K. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis. 1990 Mar-Apr;12 (Suppl 3):S318–S326. doi: 10.1093/clinids/12.supplement_3.s318. [DOI] [PubMed] [Google Scholar]
  3. Como J. A., Dismukes W. E. Oral azole drugs as systemic antifungal therapy. N Engl J Med. 1994 Jan 27;330(4):263–272. doi: 10.1056/NEJM199401273300407. [DOI] [PubMed] [Google Scholar]
  4. Fakjian N., Hunter S., Cole G. W., Miller J. An argument for circumcision. Prevention of balanitis in the adult. Arch Dermatol. 1990 Aug;126(8):1046–1047. [PubMed] [Google Scholar]
  5. Kinghorn G. R., Woolley P. D. Single-dose fluconazole in the treatment of Candida albicans balanoposthitis. Int J STD AIDS. 1990 Sep;1(5):366–367. doi: 10.1177/095646249000100516. [DOI] [PubMed] [Google Scholar]
  6. Lazar J. D., Hilligoss D. M. The clinical pharmacology of fluconazole. Semin Oncol. 1990 Jun;17(3 Suppl 6):14–18. [PubMed] [Google Scholar]
  7. Lefevre J. C., Lepargneur J. P., Bauriaud R., Bertrand M. A., Blanc C. Clinical and microbiologic features of urethritis in men in Toulouse, France. Sex Transm Dis. 1991 Apr-Jun;18(2):76–79. doi: 10.1097/00007435-199118020-00004. [DOI] [PubMed] [Google Scholar]
  8. Masterton G., Sengupta S. M., Schofield C. B. Natamycin in genital candidosis in men. Br J Vener Dis. 1975 Jun;51(3):210–212. doi: 10.1136/sti.51.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Maw R. D., Horner T., Evans J. A comparative trial of bifonazole 1% cream and clotrimazole 1% cream in the treatment of candidal balanoposthitis. Mykosen. 1987 May;30(5):229–232. doi: 10.1111/j.1439-0507.1987.tb03972.x. [DOI] [PubMed] [Google Scholar]
  10. Pariser D. M. Cutaneous candidiasis. A practical guide for primary care physicians. Postgrad Med. 1990 May 1;87(6):101-3, 106-8. doi: 10.1080/00325481.1990.11716334. [DOI] [PubMed] [Google Scholar]
  11. Patel H. S., Peters M. D., 2nd, Smith C. L. Is there a role for fluconazole in the treatment of vulvovaginal candidiasis? Ann Pharmacother. 1992 Mar;26(3):350–353. doi: 10.1177/106002809202600309. [DOI] [PubMed] [Google Scholar]
  12. Tosi E., Bertani E., Pavone P. S., Bianchi W., Viscovo R. 1% bifonazole cream in the treatment of Candida balanitis: a clinical trial. Riv Eur Sci Med Farmacol. 1987 Sep;9(3):265–267. [PubMed] [Google Scholar]
  13. Vohra S., Badlani G. Balanitis and balanoposthitis. Urol Clin North Am. 1992 Feb;19(1):143–147. [PubMed] [Google Scholar]
  14. Waugh M. A. Clinical presentation of candidal balanitis--its differential diagnosis and treatment. Chemotherapy. 1982;28 (Suppl 1):56–60. doi: 10.1159/000238154. [DOI] [PubMed] [Google Scholar]
  15. Waugh M. A., Evans E. G., Nayyar K. C., Fong R. Clotrimazole (Canesten) in the treatment of candidal balanitis in men. With incidental observations on diabetic candidal balanoposthitis. Br J Vener Dis. 1978 Jun;54(3):184–186. doi: 10.1136/sti.54.3.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wise G. J., Silver D. A. Fungal infections of the genitourinary system. J Urol. 1993 Jun;149(6):1377–1388. doi: 10.1016/s0022-5347(17)36396-6. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES